Indacaterol improves lung hyperinflation and physical activity in patients with moderate chronic obstructive pulmonary disease - a randomized, multicenter, double-blind, placebo-controlled study
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Indacaterol improves lung hyperinflation and physical activity in patients with moderate chronic obstructive pulmonary disease - a randomized, multicenter, double-blind, placebo-controlled study
Authors
Keywords
Chronic obstructive pulmonary disease, Lung hyperinflation, Bronchodilator treatment, Physical activity
Journal
BMC Pulmonary Medicine
Volume 14, Issue 1, Pages -
Publisher
Springer Nature
Online
2014-10-04
DOI
10.1186/1471-2466-14-158
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Improving physical activity in COPD: towards a new paradigm
- (2013) Thierry Troosters et al. RESPIRATORY RESEARCH
- Indacaterol on dyspnea in chronic obstructive pulmonary disease: a systematic review and meta-analysis of randomized placebo-controlled trials
- (2013) Jiangna Han et al. BMC Pulmonary Medicine
- Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
- (2012) Jørgen Vestbo et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Prognostic Value of the Objective Measurement of Daily Physical Activity in Patients With COPD
- (2012) Francisco Garcia-Rio et al. CHEST
- Quadriceps wasting and physical inactivity in patients with COPD
- (2012) Dinesh Shrikrishna et al. EUROPEAN RESPIRATORY JOURNAL
- Validity of Six Activity Monitors in Chronic Obstructive Pulmonary Disease: A Comparison with Indirect Calorimetry
- (2012) Hans Van Remoortel et al. PLoS One
- Clinical trial design in chronic obstructive pulmonary disease: current perspectives and considerations with regard to blinding of tiotropium
- (2012) Kai-Michael Beeh et al. RESPIRATORY RESEARCH
- Physical Activity Is the Strongest Predictor of All-Cause Mortality in Patients With COPD
- (2011) Benjamin Waschki et al. CHEST
- Effect of Indacaterol on Dynamic Lung Hyperinflation and Breathlessness in Hyperinflated Patients with COPD
- (2011) Kai-Michael Beeh et al. COPD-Journal of Chronic Obstructive Pulmonary Disease
- Minimum amount of physical activity for reduced mortality and extended life expectancy: a prospective cohort study
- (2011) Chi Pang Wen et al. LANCET
- Effect of indacaterol on exercise endurance and lung hyperinflation in COPD
- (2011) Denis E. O’Donnell et al. RESPIRATORY MEDICINE
- Body plethysmography – Its principles and clinical use
- (2011) C.P. Criée et al. RESPIRATORY MEDICINE
- Acute effects of indacaterol on lung hyperinflation in moderate COPD: A comparison with tiotropium
- (2011) Andrea Rossi et al. RESPIRATORY MEDICINE
- Physical activity monitoring in COPD: Compliance and associations with clinical characteristics in a multicenter study
- (2011) Benjamin Waschki et al. RESPIRATORY MEDICINE
- Physical inactivity in patients with COPD, a controlled multi-center pilot-study
- (2010) Thierry Troosters et al. RESPIRATORY MEDICINE
- Measurement properties of the SenseWear armband in adults with chronic obstructive pulmonary disease
- (2010) K. Hill et al. THORAX
- Consequences of physical inactivity in chronic obstructive pulmonary disease
- (2010) Jorine E Hartman et al. Expert Review of Respiratory Medicine
- Daily Physical Activity in Patients with Chronic Obstructive Pulmonary Disease Is Mainly Associated with Dynamic Hyperinflation
- (2009) Francisco Garcia-Rio et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Physical activity in patients with COPD
- (2008) H. Watz et al. EUROPEAN RESPIRATORY JOURNAL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More